Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKB

This study demonstrates that CDKL3 regulates Akt activation and its downstream targets to promote OS progression, creating a therapeutically targetable vulnerability in treatment of OS.

Detalles Bibliográficos
Autores principales: He, Aina, Ma, Lanjing, Huang, Yujing, Zhang, Haijiao, Duan, Wei, Li, Zexu, Fei, Teng, Yuan, Junqing, Wu, Hao, Liu, Liguo, Bai, Yueqing, Dai, Wentao, Wang, Yonggang, Li, Hongtao, Sun, Yong, Wang, Yaling, Wang, Chunyan, Yuan, Ting, Yang, Qingcheng, Tian, Songhai, Dong, Min, Sheng, Ren, Xiang, Dongxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2022
Materias:
Corrections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603691/
https://www.ncbi.nlm.nih.gov/pubmed/36270774
http://dx.doi.org/10.26508/lsa.202201656

Ejemplares similares

Ejemplares similares